View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Notice Summary

Title:
United Kingdom-Cambridge: Homecare Medicines Services for Immunoglobulin Therapies
Document Ref:
46222-2020
Document Type:
Contract Notice - Open Procedure
Published By:
East of England NHS Collaborative Hub c/o West Suffolk NHS Foundation Trust
Date Published:
30 January 2020
Deadline Date:
03 March 2020
Document Source:
Framework/DPS:
Yes
Alert Profile:
Labels:

Notice Abstract

The East of England NHS Collaborative Procurement Hub (the Authority) is procuring a framework agreement for the provision of homecare medicines services for immunoglobulin therapy. This is for the dispensing and delivery of immunoglobulin products with associated equipment and ancillaries required for administration as well as options for associated nurse led care in the patients home and includes:— intravenous immunoglobulin products,— sub-cutaneous immunoglobulin products,— patient self-injection training,— product administration in the patients home.Estimated value at ~ 100 000 000 GBP for full maximum term. ~ 25 000 000 GBP p.a. across EoECPH members (including affiliate members).

Notice Details

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

East of England NHS Collaborative Hub c/o West Suffolk NHS Foundation Trust

Victoria House, Capital Park, Fulbourn

Cambridge

UK

E-mail: pharmacy@eoecph.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://www.eoecph.nhs.uk

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

http://www.eoecph.bravosolution.co.uk


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

http://www.eoecph.bravosolution.co.uk


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Homecare Medicines Services for Immunoglobulin Therapies

II.1.2) Main CPV code

85149000

 

II.1.3) Type of contract

Services

II.1.4) Short description

The East of England NHS Collaborative Procurement Hub (the Authority) is procuring a framework agreement for the provision of homecare medicines services for immunoglobulin therapy. This is for the dispensing and delivery of immunoglobulin products with associated equipment and ancillaries required for administration as well as options for associated nurse led care in the patients home and includes:

— intravenous immunoglobulin products,

— sub-cutaneous immunoglobulin products,

— patient self-injection training,

— product administration in the patients home.

Estimated value at ~ 100 000 000 GBP for full maximum term. ~ 25 000 000 GBP p.a. across EoECPH members (including affiliate members).

II.1.5) Estimated total value

Value excluding VAT: 100 000 000.00 GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS code:

UK

Main site or place of performance:

Most EoECPH members are situated in the East of England geographical region. The EoECPH has existing affiliate members in Thames Valley and Wessex and South East Coast.

II.2.4) Description of the procurement

The East of England NHS Collaborative Procurement Hub (the Authority) is procuring a framework agreement for the provision of homecare medicines services for immunoglobulin therapy. Broadly this covers the dispensing and delivery of immunoglobulin products with associated equipment and ancillaries required for administration as well as options for associated nurse led care in the patients home and includes:

— intravenous immunoglobulin,

— subcutaneous immunoglobulin,

— dispensing and delivery of immunoglobulin with associated equipment and ancillaries required for administration,

— patient self-injection training,

— product administration in the patients home.

The framework agreement will be for East of England NHS Collaborative Procurement Hub (EoECPH) members.

Subject to successful application for associate membership this framework agreement will include and be for the benefit of any publicly funded (both wholly and partially funded) entity in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will include, but is not limited to: acute, ambulance, mental health, clinical commissioning groups, health and care trusts, area teams, local authorities and special health authorities, HSC in Northern Ireland, NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers. Please follow the links below to identify specific organisations:

— NHS trusts: http://www.nhs.uk/ServiceDirectories/Pages/AcuteTrustListing.aspx

— Clinical Commissioning Groups: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx

— Area Teams: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx

— Local Authorities: https://www.lgbce.org.uk/records-and-resources/local-authorities-in-england

— Special health authorities: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx

— HSC in Northern Ireland: http://online.hscni.net/other-hsc-organisations

— NHS Scotland:http://www.scot.nhs.uk/organisations/

— NHS Wales:http://www.wales.nhs.uk/ourservices/directory

Estimated value at ~ 25 000 000 GBP p.a. across EoECPH members (including affiliate members).

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 100 000 000.00 GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24

This contract is subject to renewal: Yes

Description of renewals:

Option to extend for 2 x 12 month periods.

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement with several operators.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 03/03/2020

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 3 (from the date stated for receipt of tender)

IV.2.7) Conditions for opening of tenders

Date: 03/03/2020

Local time: 12:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: Yes

Estimated timing for further notices to be published:

2024.

VI.4) Procedures for review

VI.4.1) Review body

NHS Resolution

2nd Floor, 151 Buckingham Palace Road

London

SW1W 9SZ

UK

VI.5) Date of dispatch of this notice

28/01/2020

Current Notes